Donald Silver

5.8k total citations · 1 hit paper
151 papers, 4.6k citations indexed

About

Donald Silver is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Donald Silver has authored 151 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Surgery, 39 papers in Pulmonary and Respiratory Medicine and 35 papers in Internal Medicine. Recurrent topics in Donald Silver's work include Venous Thromboembolism Diagnosis and Management (35 papers), Heparin-Induced Thrombocytopenia and Thrombosis (27 papers) and Platelet Disorders and Treatments (12 papers). Donald Silver is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (35 papers), Heparin-Induced Thrombocytopenia and Thrombosis (27 papers) and Platelet Disorders and Treatments (12 papers). Donald Silver collaborates with scholars based in United States, Germany and United Kingdom. Donald Silver's co-authors include Warren D.W. Heston, I Pellicer, Carlos Cordon‐Cardo, Jerry Laster, W. Kirt Nichols, Dolores F. Cikrit, Glen R. Rhodes, Richard H. Dixon, Jack J. Curtis and Theodore H. Spaet and has published in prestigious journals such as Neurology, Journal of Bone and Joint Surgery and Stroke.

In The Last Decade

Donald Silver

141 papers receiving 4.3k citations

Hit Papers

Prostate-specific membran... 1997 2026 2006 2016 1997 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Donald Silver 2.1k 1.9k 996 832 751 151 4.6k
Lubica Rauova 1.5k 0.7× 368 0.2× 677 0.7× 179 0.2× 235 0.3× 94 3.4k
Philippe Dartevelle 3.0k 1.4× 6.6k 3.5× 677 0.7× 241 0.3× 2.6k 3.4× 176 9.3k
Peter S. Rose 3.8k 1.8× 2.6k 1.4× 249 0.3× 348 0.4× 596 0.8× 294 7.5k
H. Jürgens 1.2k 0.6× 3.4k 1.8× 103 0.1× 162 0.2× 1.0k 1.3× 138 5.4k
Catalin Toma 2.1k 1.0× 307 0.2× 904 0.9× 245 0.3× 1.1k 1.5× 115 4.3k
Olaf Mercier 1.7k 0.8× 3.9k 2.1× 324 0.3× 199 0.2× 1.9k 2.5× 251 5.6k
Mathias Freund 1.3k 0.6× 423 0.2× 146 0.1× 183 0.2× 448 0.6× 178 6.5k
Richard A. Schatz 5.4k 2.6× 2.4k 1.2× 396 0.4× 2.1k 2.5× 3.3k 4.5× 108 7.3k
C.N. Chesterman 403 0.2× 160 0.1× 216 0.2× 576 0.7× 237 0.3× 40 2.6k
Manfred Cejna 3.0k 1.4× 2.9k 1.5× 331 0.3× 200 0.2× 604 0.8× 92 4.4k

Countries citing papers authored by Donald Silver

Since Specialization
Citations

This map shows the geographic impact of Donald Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Silver more than expected).

Fields of papers citing papers by Donald Silver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Silver. The network helps show where Donald Silver may publish in the future.

Co-authorship network of co-authors of Donald Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Silver. A scholar is included among the top collaborators of Donald Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Silver. Donald Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mureebe, Leila, et al.. (2004). Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients. Surgery. 136(4). 848–853. 27 indexed citations
2.
Mureebe, Leila, et al.. (2003). Heparin-induced thrombocytopenia: twenty-nine years later. Journal of Vascular Surgery. 38(6). 1316–1322. 28 indexed citations
3.
Mureebe, Leila & Donald Silver. (2002). Heparin-Induced Thrombocytopenia: Pathophysiology and Management. Vascular and Endovascular Surgery. 36(3). 163–170. 22 indexed citations
4.
Spadone, Donald P., et al.. (2002). Abdominal Aortic Sarcoma: Report of a Case with Long-term Survival and Review of the Literature. Annals of Vascular Surgery. 16(5). 545–549. 26 indexed citations
5.
Liem, Timothy K., et al.. (2001). Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies. Journal of Vascular Surgery. 34(1). 17–20. 17 indexed citations
6.
Liem, Timothy K., et al.. (1999). The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction. Journal of Vascular Surgery. 29(5). 779–786. 29 indexed citations
7.
Almeida, José I., Timothy K. Liem, & Donald Silver. (1998). Heparin-bonded grafts induce platelet aggregation in the presence of heparin-associated antiplatelet antibodies. Journal of Vascular Surgery. 27(5). 896–901. 10 indexed citations
8.
Almeida, José I., et al.. (1998). Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome. Journal of Vascular Surgery. 27(2). 309–316. 43 indexed citations
9.
Adams, John G., et al.. (1996). Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome. Journal of Vascular Surgery. 23(5). 839–843. 26 indexed citations
10.
Loy, Timothy S., et al.. (1995). Neodymium:yttrium-aluminum-garnet laser fusion of endarterectomy flaps. Journal of Vascular Surgery. 22(1). 32–36. 1 indexed citations
11.
Adams, John G., Loren J. Humphrey, Xinchao Zhang, & Donald Silver. (1995). Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies?. Journal of Vascular Surgery. 21(2). 247–254. 7 indexed citations
12.
Kikta, Michael J., et al.. (1993). Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?. PubMed. 114(4). 705–10. 56 indexed citations
13.
Walls, Joseph T., Jack J. Curtis, Donald Silver, et al.. (1992). Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognition. The Annals of Thoracic Surgery. 53(5). 787–791. 86 indexed citations
14.
Silver, Donald, et al.. (1991). Venous thromboembolic disorders. Journal of Vascular Surgery. 13(5). 1A–1A. 10 indexed citations
15.
Recht, Lawrence D., Gitte Strauss, Thomas J. FitzGerald, et al.. (1990). Preirradiation Chemotherapy of Supratentorial Malignant Primary Brain Tumors with Intracarotid cis-Platinum (CDDP) and i.v. BCNU. American Journal of Clinical Oncology. 13(2). 125–131. 31 indexed citations
16.
Walls, Joseph T., Zuhdi Lababidi, Jack J. Curtis, & Donald Silver. (1984). Assessment of percutaneous balloon pulmonary and aortic valvuloplasty. Journal of Thoracic and Cardiovascular Surgery. 88(3). 352–356. 93 indexed citations
17.
Gervin, Alfred S., J. Frederick McNeer, Walter G. Wolfe, Charles L. Puckett, & Donald Silver. (1974). Ultrapore hemofiltration during extracorporeal circulation. Journal of Thoracic and Cardiovascular Surgery. 67(2). 237–242. 6 indexed citations
18.
Porter, John M., et al.. (1971). Mesothelial fibrinolysis. Journal of Thoracic and Cardiovascular Surgery. 62(5). 725–730. 33 indexed citations
19.
Porter, John M., Donald Silver, & David C. Sabiston. (1968). Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 56(6). 869–878. 39 indexed citations
20.
Silver, Donald, et al.. (1965). Relationship of blood serotonin to argentaffin activity in the proximal jejunum during the experimental dumping response.. PubMed. 16. 369–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026